PROCEDURA APERTA PER L’AFFIDAMENTO AD UNA CONTRACT RESEARCH ORGANIZATION (CRO) DEI SERVIZI PER LA GESTIONE DELLO STUDIO CLINICO MULTICENTRICO RANDOMIZZATO: “COMBOSEQ - SEQUENCE STRATEGY OF IMMUNEONCOLOGY (IO-IO) VS IO-TYROSINE KINASE INHIBITORS (TKI) FOLLOWED BY TKI IN METASTATIC RENAL CELL CARCINOMA (MRCC): A RANDOMIZED PHASE 3 STUDY MEETURO AND FICOG TRIAL”, MEDIANTE PIATTAFORMA SINTEL
- Buyer
- FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI, MILANO
- Country
- Italy
- Published
- 4 Nov 2026
- Deadline
- 24 Nov 2026 (earliest lot deadline; time and time zone in the official notice)
- Procedure
- open
- Contract nature
- services
- Estimated value
- €2,024,000 (sum of published lots)
- CPV
- 75122000 (Public administration services)
Description (original language)
PROCEDURA APERTA PER L’AFFIDAMENTO AD UNA CONTRACT RESEARCH ORGANIZATION (CRO) DEI SERVIZI PER LA GESTIONE DELLO STUDIO CLINICO MULTICENTRICO RANDOMIZZATO: “COMBOSEQ - SEQUENCE STRATEGY OF IMMUNEONCOLOGY (IO-IO) VS IO-TYROSINE KINASE INHIBITORS (TKI) FOLLOWED BY TKI IN METASTATIC RENAL CELL CARCINOMA (MRCC): A RANDOMIZED PHASE 3 STUDY MEETURO AND FICOG TRIAL”, MEDIANTE PIATTAFORMA SINTEL PREVISTA CLAUSOLA DI ADESIONE EX-POST DEL 300% A FAVORE DEGLI ENTI DEL CONSORZIO, COMPRESA LA FONDAZIONE, DI CUI ALL'ART. 2 DEL DISCIPLINARE DI GARA
Notices can be corrected or cancelled by the buyer. The official notice on TED always prevails.
Source: TED, Publications Office of the EURetrieved: